Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

19.10.2026

2 AIDS Res Hum Retroviruses
2 Am J Epidemiol
6 Clin Infect Dis
6 HIV Med
11 J Acquir Immune Defic Syndr
3 J Infect Dis
2 J Virol
1 Lancet Infect Dis
1 N Engl J Med
1 Nat Med
1 Pediatr Infect Dis J
1 Pediatrics
5 PLoS One
1 PLoS Pathog
1 Vaccine



    AIDS Res Hum Retroviruses


  1. Erratum to: "Experiences and Acceptability of Serial Lymph Node and Gut Biopsies Among Young Women Enrolled in an HIV Cure-Related Trial in Durban, South Africa".
    AIDS Res Hum Retroviruses. 2026 Oct 14:8892229261499853.
    >> Share

  2. TAHER L, Arellano J, Al-Harthi L
    Revisiting What HIV in the Brain Can Teach Us About SARS-CoV-2 Neurological Complications.
    AIDS Res Hum Retroviruses. 2026 Oct 13:8892229261491499.
    >> Share


    Am J Epidemiol

  3. LESKO CR, Kurgansky K, Humes E, Kasaie P, et al
    The effect of hypothetical interventions to limit weight gain on incident type 2 diabetes mellitus among people with HIV initiating antiretroviral therapy in the United States, 2012-2021.
    Am J Epidemiol. 2026 Oct 14:kwag255. doi: 10.1093.
    >> Share

  4. SI C, Stephens DA, Moodie EEM, Marbaniang I, et al
    Estimate Optimal Dynamic Treatment Regimes with Partial Compatibility: An Application to data from a TREAT Asia HIV Observational Database (TAHOD) site in Pune, India.
    Am J Epidemiol. 2026 Oct 13:kwag254. doi: 10.1093.
    >> Share


    Clin Infect Dis

  5. KASAMATSU A, Tomo Y
    Estimating Cancer Progression Risk by HIV Status: Design and Interpretation of Real-World Comparisons.
    Clin Infect Dis. 2026 Oct 16:ciag651. doi: 10.1093.
    >> Share

  6. SCHNEIDER D, Van Bibber NW, Islam JY, Coghill AE, et al
    HIV and Cancer Progression: Interpreting Real-World Evidence.
    Clin Infect Dis. 2026 Oct 16:ciag652. doi: 10.1093.
    >> Share

  7. DESCHANVRES C, Hocqueloux L, Cabie A, Robert C, et al
    Risk Factors and Therapeutic Consequences of Virologic Failure With Long-Acting Cabotegravir Plus Rilpivirine in the Dat'AIDS Cohort.
    Clin Infect Dis. 2026 Oct 14:ciag654. doi: 10.1093.
    >> Share

  8. CASADO JL, Vallejo A
    Low Baseline RPR Titers and Serological Response: Persistent Questions Among People with HIV.
    Clin Infect Dis. 2026 Oct 13:ciag645. doi: 10.1093.
    >> Share

  9. YILMAZ E, Koker Ozer N, Topal E
    Does Low Baseline RPR Reflect Treatment Failure or Serologic Response Dynamics in Syphilis Among People With HIV?
    Clin Infect Dis. 2026 Oct 13:ciag643. doi: 10.1093.
    >> Share

  10. MASIA M, de la Tabla AG, Garcia L, Ledesma C, et al
    Excess Hospital Use and Years of Life Lost After Cancer Diagnosis among People with HIV: A Nationwide Study in Spain.
    Clin Infect Dis. 2026 Oct 10:ciag620. doi: 10.1093.
    >> Share


    HIV Med

  11. MASQUELIER H, Nagel J, Gilles C, Delforge M, et al
    Breastfeeding and HIV in high-income settings: Exploring women living with HIV and health care providers' perspectives in Belgium.
    HIV Med. 2026 Oct 16. doi: 10.1111/hiv.70321.
    >> Share

  12. JUNIPER T, Stuart L, Kulasegaram R, Windebank F, et al
    BHIVA Audit 2023: Prior engagement in HIV care among people living with HIV admitted to hospital.
    HIV Med. 2026 Oct 15. doi: 10.1111/hiv.70330.
    >> Share

  13. BOYD A, Lutz T, van Bremen K, Tavelli A, et al
    Hepatitis D virus infection in persons with HIV and hepatitis B virus across Europe: A cross-sectional analysis of the HDV-Europe cohort.
    HIV Med. 2026 Oct 15. doi: 10.1111/hiv.70320.
    >> Share

  14. YAMASHITA K, Ikeuchi K, Sekiya R, Arisato Y, et al
    A cross-sectional analysis of cardiometabolic and lifestyle-related profiles in men living with HIV in Japan using linked nationwide claims and health checkup data.
    HIV Med. 2026 Oct 11. doi: 10.1111/hiv.70317.
    >> Share

  15. SIMON NR, Mondoka C, Thorball CW, Schoepf IC, et al
    Chronic alanine aminotransferase elevation in people with HIV: Time trends over 22 years and genetic predisposition.
    HIV Med. 2026 Oct 11. doi: 10.1111/hiv.70322.
    >> Share

  16. MOLEFE-BAIKAI OJ, Leeme TB, Mawi MK, Kebotsamang K, et al
    Gaps in diabetes care among people living with HIV and hypertension in Botswana: A cross-sectional analysis of the InterCARE study.
    HIV Med. 2026 Oct 11. doi: 10.1111/hiv.70318.
    >> Share


    J Acquir Immune Defic Syndr

  17. DAY GL, Mehta AB, Erlandson KM, Valley TS, et al
    Identifying disparities at the intersection of race and HIV in patients with sepsis and pneumonia.
    J Acquir Immune Defic Syndr. 2026 Oct 14. doi: 10.1097/QAI.0000000000003987.
    >> Share

  18. SHORER EF, Dastgheyb RM, Burgess HJ, Rubin LH, et al
    Kynurenine Pathway Activation is Associated with Poor Sleep Efficiency in Men With HIV.
    J Acquir Immune Defic Syndr. 2026 Oct 12. doi: 10.1097/QAI.0000000000003982.
    >> Share

  19. JUAREZ SI, Rugg AA, Gutierrez C, Chang L, et al
    Strengthening Panama's HIV Viral Load Testing Network through a Phased Optimization Strategy: A Retrospective Program Assessment, 2021-2025.
    J Acquir Immune Defic Syndr. 2026 Oct 12. doi: 10.1097/QAI.0000000000003977.
    >> Share

  20. SKAATHUN B, Hussain M, Davila VM, Ortiz EL, et al
    Identification of venues for HIV prevention interventions through overlapping HIV transmission and venue elicitation networks.
    J Acquir Immune Defic Syndr. 2026 Oct 12. doi: 10.1097/QAI.0000000000003980.
    >> Share

  21. MNGQIBISA R, Kassim S, McDonald C, Bloch M, et al
    Safety and Efficacy of Doravirine/Islatravir (100 mg/0.25 mg) Once Daily after Islatravir Dose Reduction from 0.75 mg: Week 96 Results from an Open-Label Phase 3 Study in Adults with HIV-1.
    J Acquir Immune Defic Syndr. 2026 Oct 12. doi: 10.1097/QAI.0000000000003981.
    >> Share

  22. ZHENG M, Ehrig M, Cunningham HE, DuBois LZ, et al
    Cross-sectional Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk Estimates in a U.S. Cohort of Black and Latina Transgender Women with HIV.
    J Acquir Immune Defic Syndr. 2026 Oct 14. doi: 10.1097/QAI.0000000000003985.
    >> Share

  23. MAHUVAKAR S, Argueta-Rodriguez J, Montoya R, Ghanooni D, et al
    Developing a drug-level feedback adherence counseling intervention for young MSM in the U.S.
    J Acquir Immune Defic Syndr. 2026 Oct 14. doi: 10.1097/QAI.0000000000003986.
    >> Share

  24. RYSCAVAGE P, Fenn J, Patel D, Chen H, et al
    Emerging non-AIDS comorbidities among adults with and without perinatally-acquired HIV.
    J Acquir Immune Defic Syndr. 2026 Oct 15. doi: 10.1097/QAI.0000000000003989.
    >> Share

  25. ANDERSON K, Kalk E, Phillips TK, Jacob N, et al
    Improved Pregnancy Viral Load Monitoring but Persistent Postpartum Gaps After Guideline Changes: A Population-Based Analysis in the Western Cape, South Africa (2018-2024).
    J Acquir Immune Defic Syndr. 2026 Oct 15. doi: 10.1097/QAI.0000000000003994.
    >> Share

  26. KHAZAN A, Pallotta AM, Sharath DB, Lehman B, et al
    Statin Prescribing and Guideline Concordance Among Adults With HIV Aged 40-75 Years in a Single Urban Outpatient HIV Clinic, 2024.
    J Acquir Immune Defic Syndr. 2026 Oct 15. doi: 10.1097/QAI.0000000000003993.
    >> Share

  27. EDELMAN EJ, Deng Y, Dziura J, Weiss J, et al
    Unhealthy alcohol use's impact on clinical pharmacist-delivered tobacco treatment among persons with HIV: An exploratory analysis of a randomized clinical trial.
    J Acquir Immune Defic Syndr. 2026 Oct 15. doi: 10.1097/QAI.0000000000003992.
    >> Share


    J Infect Dis

  28. DOHERTY K, Hamilton J, Nthandira T, Chirwa AE, et al
    Experimental pneumococcal carriage reveals humoral correlates of susceptibility in virally suppressed adults with HIV.
    J Infect Dis. 2026 Oct 15:jiag517. doi: 10.1093.
    >> Share

  29. CHAN P, Tayutivutikul K, Slike BM, Pinyakorn S, et al
    Soluble Indicators of Endothelial Injury and Activation Emerge During Acute HIV Infection and Persist Despite Rapid Antiretroviral Therapy Initiation.
    J Infect Dis. 2026 Oct 13:jiag495. doi: 10.1093.
    >> Share

  30. CHANG BH, Hargarten JC, Ssebambulidde K, Scott T, et al
    Long-term Outcomes in Previously Healthy non-HIV Individuals with Cryptococcal Meningitis Treated with Pulse-taper Corticosteroids for Post-infectious Inflammatory Syndrome.
    J Infect Dis. 2026 Oct 12:jiag511. doi: 10.1093.
    >> Share


    J Virol

  31. BANGHAM CRM, Matsuoka M
    Primer: Human T-cell leukemia virus type 1 (HTLV-1).
    J Virol. 2026 Oct 14:e0118326. doi: 10.1128/jvi.01183.
    >> Share

  32. BERTELLI C, Rosa A, Vanzo T, Crescioli I, et al
    SERINC5 is the primary target of retroviral antagonists among human SERINC paralogs and requires a tri-cysteine motif for its counteraction by HIV-1 Nef.
    J Virol. 2026 Oct 12:e0108826. doi: 10.1128/jvi.01088.
    >> Share


    Lancet Infect Dis

  33. HOLT E
    Disruption of HIV services in Ukraine.
    Lancet Infect Dis. 2026 Oct 15:S1473-3099(26)00575.
    >> Share


    N Engl J Med

  34. CRESSWELL FV, Kitonsa J, Norcross C, Tumusiime V, et al
    Long-Acting HIV Therapy in African Adults with Adherence Challenges.
    N Engl J Med. 2026;395:1505-1518.
    >> Share


    Nat Med

  35. NASOMSONG W, Li JZ
    Autologous and broadly neutralizing antibodies drive ART-free HIV control.
    Nat Med. 2026 Oct 13. doi: 10.1038/s41591-026-04714.
    >> Share


    Pediatr Infect Dis J

  36. BARDAY MA, Hulsman C, Mc Gregor SF, van Niekerk M, et al
    Post-COVID-19 Patterns of Respiratory Viruses in South African Children With Acute Respiratory Illness.
    Pediatr Infect Dis J. 2026 Oct 14. doi: 10.1097/INF.0000000000005427.
    >> Share


    Pediatrics

  37. OWERKO D, Burek A, Watson J
    An Adolescent With Neurosyphilis.
    Pediatrics. 2026 Oct 14:e2026076004. doi: 10.1542/peds.2026-076004.
    >> Share


    PLoS One

  38. ANAND PK, Singh M, Banerjee P, Sahay S, et al
    Self-reported prevalence of tuberculosis and selected associated vulnerability factors among rural populations in six districts of India: A community-based cross-sectional study.
    PLoS One. 2026;21:e0360758.
    >> Share

  39. ONZIA AA, Twimukye A, Melendez JH, Hamill MM, et al
    Client, health care provider, and policymaker perspectives on point-of-care/near-point-of-care testing for sexually transmitted infections in community pharmacies in Uganda.
    PLoS One. 2026;21:e0347364.
    >> Share

  40. PUNJANI N, Zhang TR, Basourakos SP, Barone MA, et al
    Cost comparison of the ShangRing device versus Mogen clamp for early infant male circumcision in Sub-Saharan Africa.
    PLoS One. 2026;21:e0360356.
    >> Share

  41. MAGHEMBE RS
    Cross-omics mapping of the human HIV restrictome across clinical states, immune-cell compartments, and protein responses.
    PLoS One. 2026;21:e0356591.
    >> Share

  42. RACHMAN BE, Supranoto YTN, Nurannisa FR, Saroh SM, et al
    Predictors of immunological non-response despite virological suppression in people living with HIV on antiretroviral therapy: A systematic review and meta-analysis.
    PLoS One. 2026;21:e0358793.
    >> Share


    PLoS Pathog

  43. MANION M, Lange CM, Ortega-Villa AM, Fennessey CM, et al
    HIV-1 compartmentalization in the central nervous system during cryptococcal meningitis: Analysis of viral, fungal, and host factors.
    PLoS Pathog. 2026;22:e1014697.
    >> Share


    Vaccine

  44. HAMMOUD M, Holt M, Broady TR, Grulich A, et al
    High willingness to receive a vaccine for gonorrhoea prevention among gay, bisexual, queer, and other sexuality diverse men, and non-binary people in Australia.
    Vaccine. 2026;94:129233.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016